CDT

Conduit Pharmaceuticals Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website conduitpharma.com
Employees(FY) -
ISIN US20678X1063

Performance

+10.76%

-2.07%

-33.97%

-96.53%

-97.71%

YTD

-94.22%

Profile

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Advanced Technical Analysis

Technical Analysis of CDT 2024-11-22

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 30, the Oscillators Score at 46, and the overall Technical Score at 38, indicating a lack of upward momentum and potential weakness in the stock's performance. This combination suggests caution for investors, as the majority of indicators point towards a negative ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CDT

Stock Rank

Recent News & Updates

2024-11-20 18:30
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders(Globenewswire)
2024-11-19 03:30
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors(Globenewswire)
2024-11-04 18:40
Conduit Pharmaceuticals announces new addition to autoimmune pipeline(Yahoo Finance)
2024-11-03 18:30
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline(Globenewswire)
2024-11-01 04:45
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes(Globenewswire)
2024-08-27 20:00
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference(Globenewswire)
2024-08-11 19:00
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders(Globenewswire)
2024-08-07 18:30
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments(Globenewswire)
2024-07-16 02:52
Conduit Pharmaceuticals Granted Patent Approval For Autoimmune Diseases Treatment(Yahoo Finance)
2024-07-15 20:12
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?(Investorplace)
2024-07-15 19:43
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday(Investorplace)
2024-07-15 19:30
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases(Globenewswire)
2024-06-12 20:00
Conduit Pharmaceuticals to Join Russell 3000 Index(Globenewswire)
2024-05-29 04:21
A Presidio Property Trust Major Investment To Be Part of Russell 2000(Globenewswire)
2024-05-14 21:53
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q1 2024(Investorplace)
2024-03-18 22:57
Conduit Pharmaceuticals Adds Key Leadership Positions(Yahoo Finance)
2024-03-18 19:00
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer(Globenewswire)
2024-03-11 02:26
Conduit Pharmaceuticals Opens New Laboratory in UK(Yahoo Finance)
2024-03-10 19:00
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub(Globenewswire)
2024-01-30 19:30
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference(Globenewswire)
2023-11-01 20:30
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference(Globenewswire)
2023-10-29 20:39
Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?(Investorplace)
2023-10-10 20:30
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656(Globenewswire)
2023-10-05 21:29
Conduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipeline(Yahoo Finance)
2023-10-05 20:30
Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)(Globenewswire)
2023-09-21 21:01
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination(Yahoo Finance)
2023-09-20 05:40
Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited(Yahoo Finance)
2023-09-12 20:30
Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives(Yahoo Finance)
2023-09-07 04:30
Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit(Yahoo Finance)
2023-08-31 04:05
Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit(Yahoo Finance)

Page 1 of 2

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.